Revolution Medicines (RVMD) Current Leases (2020 - 2025)
Historic Current Leases for Revolution Medicines (RVMD) over the last 6 years, with Q3 2025 value amounting to $16.3 million.
- Revolution Medicines' Current Leases rose 9444.97% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.3 million, marking a year-over-year increase of 9444.97%. This contributed to the annual value of $12.9 million for FY2024, which is 7467.77% up from last year.
- Revolution Medicines' Current Leases amounted to $16.3 million in Q3 2025, which was up 9444.97% from $13.1 million recorded in Q2 2025.
- In the past 5 years, Revolution Medicines' Current Leases registered a high of $16.3 million during Q3 2025, and its lowest value of $3.7 million during Q1 2021.
- In the last 5 years, Revolution Medicines' Current Leases had a median value of $6.8 million in 2022 and averaged $7.9 million.
- Its Current Leases has fluctuated over the past 5 years, first crashed by 1798.49% in 2023, then soared by 9444.97% in 2025.
- Quarter analysis of 5 years shows Revolution Medicines' Current Leases stood at $6.2 million in 2021, then rose by 9.0% to $6.8 million in 2022, then grew by 8.8% to $7.4 million in 2023, then surged by 74.68% to $12.9 million in 2024, then rose by 26.83% to $16.3 million in 2025.
- Its last three reported values are $16.3 million in Q3 2025, $13.1 million for Q2 2025, and $13.0 million during Q1 2025.